Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 21273-21274 [2020-07970]

Download as PDF jbell on DSKJLSW7X2PROD with NOTICES Federal Register / Vol. 85, No. 74 / Thursday, April 16, 2020 / Notices women and men in scientific and engineering positions.’’ NCSES has historically met these legislative mandates through its suite of surveys and biennial publications that measure the education, employment, and demographic characteristics of the nation’s college-educated scientists and engineers. However, an emerging research and policy interest in the STW creates a need for new data to expand and supplement NCSES’s efforts on the college-educated science and engineering workforce. Expected Respondents: All previous respondents to the 2018 American Community Survey, collected by the U.S. Census Bureau, are eligible to be selected to participate in the initial NTEWS. Approximately 40,000 adults, ages 16–75 and not enrolled in high school, will be selected for the NTEWS sample. The NTEWS sample design will meet the needs of both NCSES and NCES by providing coverage of the workforce-eligible adult population and including an oversample of adults who are in skilled technical occupations. Estimate of Burden: The expected response rate is 62.5 percent, or 25,000 completed cases. The amount of time to complete the survey may vary depending on an individual’s circumstances and the mode of the collection (web, paper, or telephone). NCSES estimates an average completion time of 15 minutes. NCSES estimates that the average annual burden for the initial NTEWS over the course of the three-year OMB clearance period will be no more than 2,084 hours [(25,000 completed cases × 15 minutes)/3 years]. Comments: Comments are invited on (a) aspects of the data collection effort (including, but not limited to, the following: The availability of administrative and supplemental sources of data on the skilled technical workforce, survey content, contact strategy, and statistical methods); (b) whether the proposed collection of information is necessary for the proper performance of the functions of NCSES, including whether the information shall have practical utility; (c) the accuracy of the NCSES’s estimate of the burden of the proposed collection of information; (d) ways to enhance the quality, use, and clarity of the information on respondents, including through the use of automated collection techniques or other forms of information technology; and (e) ways to minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. VerDate Sep<11>2014 18:20 Apr 15, 2020 Jkt 250001 Dated: April 13, 2020. Suzanne H. Plimpton, Reports Clearance Officer, National Science Foundation. [FR Doc. 2020–08067 Filed 4–15–20; 8:45 am] 21273 NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice U.S. Nuclear Regulatory Commission. ACTION: Notice of Meeting. AGENCY: BILLING CODE 7555–01–P NATIONAL SCIENCE FOUNDATION The U.S. Nuclear Regulatory Commission (NRC) will convene a teleconference meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on April 30, 2020, to discuss the draft recommendations of the ACMUI COVID–19 Subcommittee. The ACMUI subcommittee’s recommendations will include its review of the impact of COVID–19 on the medical use community and potential regulatory relief measures as it relates to the medical uses of radioactive material. Meeting information, including a copy of the agenda and handouts, will be available at https:// www.nrc.gov/reading-rm/doccollections/acmui/meetings/2020.html. The agenda and handouts may also be obtained by contacting Ms. Kellee Jamerson using the information below. DATES: The teleconference meeting will be held on Thursday, April 30, 2020, 2:00 p.m. to 4:00 p.m. Eastern Time. Public Participation: Any member of the public who wishes to participate in the teleconference should contact Ms. Jamerson using the contact information below. FOR FURTHER INFORMATION CONTACT: Kellee Jamerson, (301) 415–7408; email: Kellee.Jamerson@nrc.gov. SUPPLEMENTARY INFORMATION: SUMMARY: Sunshine Act Meeting; National Science Board The National Science Board’s Committee on National Science and Engineering Policy (SEP), pursuant to NSF regulations (45 CFR part 614), the National Science Foundation Act, as amended (42 U.S.C. 1862n–5), and the Government in the Sunshine Act (5 U.S.C. 552b), hereby gives notice of the scheduling of a teleconference for the transaction of National Science Board business, as follows: Wednesday, April 22, 2020 at 4:00–5:00 p.m. EDT. TIME AND DATE: This meeting will be held by teleconference at the National Science Foundation, 2415 Eisenhower Avenue, Alexandria, VA 22314. An audio link will be available for the public. Contact the Board Office 24 hours before the teleconference to request the public audio link at nationalsciencebrd@ nsf.gov. PLACE: STATUS: Open. Chair’s opening remarks; discussion of outcomes from the committee retreat and items to be brought forth for discussion at the May NSB meeting. MATTERS TO BE CONSIDERED: CONTACT PERSON FOR MORE INFORMATION: Point of contact for this meeting is: Reba Bandyopadhyay (rbandyop@nsf.gov), 703/292–7000. Members of the public must contact the Board Office to request the public audio link by sending an email to nationalsciencebrd@nsf.gov at least 24 hours prior to the teleconference. Meeting information and updates (time, place, subject matter or status of meeting) may be found at https:// www.nsf.gov/nsb/meetings/ notices.jsp#sunshine. Please refer to the National Science Board website www.nsf.gov/nsb for additional information. Chris Blair, Executive Assistant to the National Science Board Office. [FR Doc. 2020–08179 Filed 4–14–20; 4:15 pm] BILLING CODE 7555–01–P PO 00000 Frm 00112 Fmt 4703 Sfmt 4703 Conduct of the Meeting Dr. Robert Schleipman, ACMUI Vice Chairman, will preside over the meeting. Dr. Schleipman will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Jamerson at the contact information listed above. All written statements must be received by April 27, 2020, three business days prior to the meeting, and must pertain to the topic on the agenda for the meeting. 2. Questions and comments from members of the public will be permitted during the meeting at the discretion of the ACMUI Vice Chairman. 3. The draft transcript and meeting summary will be available on ACMUI’s website https://www.nrc.gov/reading- E:\FR\FM\16APN1.SGM 16APN1 21274 Federal Register / Vol. 85, No. 74 / Thursday, April 16, 2020 / Notices [Docket No. 50–457; NRC–2020–0089] for Docket ID NRC–2020–0089. Address questions about NRC docket IDs in Regulations.gov to Jennifer Borges; telephone: 301–287–9127; email: Jennifer.Borges@nrc.gov. For technical questions, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this document. • Mail comments to: Office of Administration, Mail Stop: TWFN–7– A60M, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001, ATTN: Program Management, Announcements and Editing Staff. For additional direction on obtaining information and submitting comments, see ‘‘Obtaining Information and Submitting Comments’’ in the SUPPLEMENTARY INFORMATION section of this document. FOR FURTHER INFORMATION CONTACT: Joel S. Wiebe, Office of Nuclear Reactor Regulation, U.S. Nuclear Regulatory Commission, Washington DC 20555– 0001; telephone: 301–415–6606, email: Joel.Wiebe@nrc.gov. SUPPLEMENTARY INFORMATION: Exelon Generation Company, LLC; Braidwood Station, Unit No. 2 I. Obtaining Information and Submitting Comments Nuclear Regulatory Commission. ACTION: License amendment application; opportunity to comment, request a hearing, and petition for leave to intervene. A. Obtaining Information Please refer to Docket ID NRC–2020– 0089 when contacting the NRC about the availability of information for this action. You may obtain publiclyavailable information related to this action by any of the following methods: • Federal Rulemaking website: Go to https://www.regulations.gov and search for Docket ID NRC–2020–0089. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publiclyavailable documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301– 415–4737, or by email to pdr.resource@ nrc.gov. The proposed license amendment request, dated April 6, 2020, seeking a one-time extension of steam generator tube inspections to allow the inspections to be conducted after three operating cycles, is available in ADAMS under Accession No. ML20097J188. rm/doc-collections/acmui/meetings/ 2020.html on or about June 15, 2020. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in 10 CFR part 7. This meeting is being noticed in the Federal Register less than 15 calendar days due to the immediate need to receive recommendations from the ACMUI to develop and provide guidance to medical use licensees during the COVID–19 pandemic. Dated: April 10, 2020. Russell E. Chazell, Advisory Committee Management Officer. [FR Doc. 2020–07970 Filed 4–15–20; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION AGENCY: The U.S. Nuclear Regulatory Commission (NRC) is considering issuance of an amendment to Renewed Facility Operating License No. NPF–77, issued to Exelon Generation Company, LLC, for operation of the Braidwood Station, Unit No. 2. The proposed amendment would provide a one-time extension of steam generator tube inspections to allow the inspections to be conducted after three operating cycles instead of after the current required two operating cycles. The amendment is necessary to avoid conflicts with the Centers for Disease Control and Prevention recommendations regarding social distancing to prevent the spread of the COVID–19 virus. The amendment also avoids a possible scenario in which expertise required to conduct the inspections is lost because of COVID–19 infections. DATES: Submit comments by April 30, 2020. Requests for a hearing or petition for leave to intervene must be filed by June 15, 2020. ADDRESSES: You may submit comments by any of the following methods: • Federal Rulemaking website: Go to https://www.regulations.gov and search jbell on DSKJLSW7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:20 Apr 15, 2020 Jkt 250001 B. Submitting Comments Please include Docket ID NRC–2020– 0089 in your comment submission. The NRC cautions you not to include identifying or contact information that you do not want to be publicly disclosed in your comment submission. PO 00000 Frm 00113 Fmt 4703 Sfmt 4703 The NRC will post all comment submissions at https:// www.regulations.gov as well as enter the comment submissions into ADAMS. The NRC does not routinely edit comment submissions to remove identifying or contact information. If you are requesting or aggregating comments from other persons for submission to the NRC, then you should inform those persons not to include identifying or contact information that they do not want to be publicly disclosed in their comment submission. Your request should state that the NRC does not routinely edit comment submissions to remove such information before making the comment submissions available to the public or entering the comment into ADAMS. II. Introduction The NRC is considering issuance of an amendment to Renewed Facility Operating License No. NPF–77, issued to Exelon Generation Company, LLC, for operation of the Braidwood Station, Unit No. 2, located in Will County, Illinois. The proposed amendment would provide a one-time extension of steam generator tube inspections to allow the inspections to be conducted after three operating cycles instead of after the current required two operating cycles. The licensee states that the Centers for Disease Control and Prevention has issued recommendations advising isolation activities (e.g., social distancing, group size limitations, selfquarantining, etc.) to prevent the spread of the COVID–19 Virus. The nature of the steam generator inspections conflicts with the recommendations in that they require workers to be in close proximity to each other in a hot and radiological environment that increases the likelihood of individuals contracting COVID–19 and potentially inducing a rapid spread. Additionally, these inspections require a specialty vendor that maintains unique and complex qualifications. Losing resources due to a virus spread would cause a situation where the proper technical knowledge would not be available to satisfactorily complete this work (minimal 14-day isolation and likely to be more than one individual based on having to work in close proximity for the work). Based on an initial review, the NRC staff finds that exigent circumstances exist under 10 CFR 50.91(a)(6). The licensee and Commission need to act quickly and time does not permit a 30day prior comment period because the plant would be prevented from resuming operations following the refueling outage occurring after the E:\FR\FM\16APN1.SGM 16APN1

Agencies

NUCLEAR REGULATORY COMMISSION

[Federal Register Volume 85, Number 74 (Thursday, April 16, 2020)]
[Notices]
[Pages 21273-21274]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-07970]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of Meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a 
teleconference meeting of the Advisory Committee on the Medical Uses of 
Isotopes (ACMUI) on April 30, 2020, to discuss the draft 
recommendations of the ACMUI COVID-19 Subcommittee. The ACMUI 
subcommittee's recommendations will include its review of the impact of 
COVID-19 on the medical use community and potential regulatory relief 
measures as it relates to the medical uses of radioactive material. 
Meeting information, including a copy of the agenda and handouts, will 
be available at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2020.html. The agenda and handouts may also be obtained by 
contacting Ms. Kellee Jamerson using the information below.

DATES: The teleconference meeting will be held on Thursday, April 30, 
2020, 2:00 p.m. to 4:00 p.m. Eastern Time.
    Public Participation: Any member of the public who wishes to 
participate in the teleconference should contact Ms. Jamerson using the 
contact information below.

FOR FURTHER INFORMATION CONTACT: Kellee Jamerson, (301) 415-7408; 
email: [email protected].

SUPPLEMENTARY INFORMATION: 

Conduct of the Meeting

    Dr. Robert Schleipman, ACMUI Vice Chairman, will preside over the 
meeting. Dr. Schleipman will conduct the meeting in a manner that will 
facilitate the orderly conduct of business. The following procedures 
apply to public participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to
Ms. Jamerson at the contact information listed above. All written 
statements must be received by April 27, 2020, three business days 
prior to the meeting, and must pertain to the topic on the agenda for 
the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting at the discretion of the ACMUI Vice 
Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's website https://www.nrc.gov/reading-

[[Page 21274]]

rm/doc-collections/acmui/meetings/2020.html on or about June 15, 2020.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in 10 
CFR part 7.
    This meeting is being noticed in the Federal Register less than 15 
calendar days due to the immediate need to receive recommendations from 
the ACMUI to develop and provide guidance to medical use licensees 
during the COVID-19 pandemic.

    Dated: April 10, 2020.
Russell E. Chazell,
Advisory Committee Management Officer.
[FR Doc. 2020-07970 Filed 4-15-20; 8:45 am]
 BILLING CODE 7590-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.